Changing the paradigm for cancer treatment through the development of antigen-independent peptide drug conjugates. CGs:https://xitter.cf/t.co/VGkcjpSeXJ
Joined January 2019
- Tweets385
- Following141
- Followers200
- Likes416
Cybrexa Therapeutics Inc retweeted
The @CCAlliance and the American Cancer Society are joining forces to get people screened for colorectal cancer. So if you’re 45 years old or older, get screened! Find a screening location near you or learn more about risk factors at YourColonIs45.org.
Cybrexa Therapeutics Inc retweeted
It’s #NationalPublicHealth Week! Join us in celebrating our local community and their unique contributions to #lifesciences, as we support & encourage diversity in CT.
Check out @NPHW’s site to learn more: bit.ly/42PY15Z
#WIBCT
Cybrexa Therapeutics Inc retweeted
We’re attending the 21st Annual #Needham Virtual Healthcare Conference next week & looking forward to this year’s presentations from leaders in the industry.
#healthcare #biotech
Cybrexa Therapeutics Inc retweeted
Thanks for the shout-out! Another product of the vibrant biotech scene at Yale, thanks to @YaleOCR !
@Yale spinout, @Cybrex, Announces First Patient Dosed in Phase 1/2 Clinical Trial of CBX-12. Congrats, @ranjitbindra, #PeterGlazer, @DrRoyHerbstYale. #cancerresearch #cancer #therapeutics #yaleuniversity #techinnovation #techtransfer bit.ly/3yC8kLO
Cybrexa Therapeutics Inc retweeted
Thank you so much for the shout-out @NAR_Open we are quite excited as we test this now in the clinic! @YaleOCR @YaleCancer @YaleRadOnc @CT_Innovate #biotech #startuplife
bit.ly/3gzDsnf – at New Haven, CT
Read our latest: Leveraging the Warburg effect for tumor-specific delivery of a topoisomerase inhibitor without systemic toxicity. From @Cybrexa @ranjitbindra @YaleMed academic.oup.com/narcancer/a…
Cybrexa Therapeutics Inc retweeted
Gearing up to raise our next big round, and now the real work begins… but feeling good with this amazing team 🙌🏽 @Cybrexa @YaleOCR @YaleCancer @YaleRadOnc @CT_Innovate #biotech #startuplife
Cybrexa Therapeutics Inc retweeted
BioBoss podcast—Cybrexa co-founder & CEO Per Hellsund. apple.co/3hJPTvl bioboss.buzzsprout.com/. #cancer #intracellular #tumor #oncology #smallmolecule #therapeutics #leadership #Cybrexa #BioCT #Yale #tumormicroenvironment #biotech #biopharma #leadership #openscience
Cybrexa Therapeutics Inc retweeted
Vote for Cybrexa and our CEO, Per Hellsund, for the 2020 CT Entrepreneurship Awards!
#CTentrepreneurawards #cancerresearch #awards #tumortargeting #oncology
ctentrepreneurawards.com/Vot…
ctentrepreneurawards.com/Vot…
Cybrexa Therapeutics Inc retweeted
Cybrexa Therapeutics announced CBX-12 as the new lead development program. CBX-12 is an alphalexTM conjugate that includes the highly potent topoisomerase I inhibitor exatecan. bit.ly/2FSVH4M
Cybrexa Therapeutics Inc retweeted
Correct! @Cybrexa is “stealing the show #AACR2019” with an entirely new way to deliver PARPi’s to tumors for HRD- cancers! Thanks @ThePharmaLetter for the shout out in your article!
bit.ly/2WDnFrH – at New Haven, CT
Cybrexa Therapeutics Inc retweeted
MDACC doc Tim Yap discussing the toxicity problem with PARPi chemo combinations, a problem that @cybrexa seeks to solve, with its novel alphalex tumor targeting platform! #biotech #startuplife #disruption
